United States · FDA National Drug Code directory
TRODELVY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55135-132_2085d741-19ba-4115-bbe9-0debac82c204
- Product NDC
- 55135-132
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- SACITUZUMAB GOVITECAN
- Labeler
- Gilead Sciences, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20200422
- Source listing expiry
- 20271231
Source-listed ingredients
- SACITUZUMAB GOVITECAN — 180 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 BOX (55135-132-01) / 1 POWDER, FOR SOLUTION in 1 VIAL · 55135-132-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →